1
|
Ekin M, Akdal G, Bora E. Antisaccade error rates in first-episode psychosis, ultra-high risk for psychosis and unaffected relatives of schizophrenia: A systematic review and meta-analysis. Schizophr Res 2024; 266:41-49. [PMID: 38367611 DOI: 10.1016/j.schres.2024.02.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 05/05/2023] [Accepted: 02/13/2024] [Indexed: 02/19/2024]
Abstract
BACKGROUND Antisaccade, which is described as looking at the opposite location of the target, is an eye movements paradigm used for assessing cognitive functions in schizophrenia. Initiation and sustainment of saccades in antisaccade are managed by frontal and parietal cortical areas. Antisaccade abnormalities are well-established findings in schizophrenia. However, studies in the early phases of psychotic disorders and clinical/familial risk for psychosis reported inconsistent findings. The current systematic review aimed to review the results of studies investigating antisaccade error rates in first-episode psychosis (FEP), individuals with ultra-high-risk for psychosis (UHRP), and familial-high-risk for psychosis (FHRP) compared to healthy controls. METHOD A meta-analysis of 17 studies was conducted to quantitatively review antisaccade errors in FEP, UHR-P and FHRP. The error rate (Hedges'g) was compared between the total of 860 FEP, UHRP, FHRP, and 817 healthy controls. Hedges' g for effect size, I2 for estimating the percentage of variability, and publication bias were evaluated through the R software. RESULTS The outcomes of this meta-analysis suggested that FEP is associated with a robust deficit in the antisaccade error rate (g = 1.16, CI = 0.95-1.38). Additionally, both the clinical and familial high-risk groups showed small but significant increases in AS errors (g = 0.26, CI = 0.02-0.52 and g = 0.34, CI = 0.13-0.55, respectively). CONCLUSION The large effect size estimated for FEP was compatible with previously reported results in chronic schizophrenia patients. Additionally, relatives had abnormalities with small to medium effect sizes and significant differences. The current findings suggest that antisaccade errors might be a potential endophenotype for psychotic disorders.
Collapse
Affiliation(s)
- Merve Ekin
- Department of Neurosciences, Institute of Health Sciences, Dokuz Eylül University, Izmir, Turkey; Institude of Psychology, SWPS University, Warsaw, Poland.
| | - Gülden Akdal
- Department of Neurosciences, Institute of Health Sciences, Dokuz Eylül University, Izmir, Turkey; Department of Neurology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.
| | - Emre Bora
- Department of Neurosciences, Institute of Health Sciences, Dokuz Eylül University, Izmir, Turkey; Department of Psychiatry, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey; Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, Victoria, Australia.
| |
Collapse
|
2
|
Karpouzian-Rogers T, Sweeney JA, Rubin LH, McDowell J, Clementz BA, Gershon E, Keshavan MS, Pearlson GD, Tamminga CA, Reilly JL. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum. Schizophr Res 2022; 248:79-88. [PMID: 35963057 DOI: 10.1016/j.schres.2022.07.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2020] [Revised: 04/29/2022] [Accepted: 07/25/2022] [Indexed: 11/19/2022]
Abstract
Task-evoked pupillary response (TEPR) is a measure of physiological arousal modulated by cognitive demand. Healthy individuals demonstrate greater TEPR prior to correct versus error antisaccade trials and correct antisaccade versus visually guided saccade (VGS) trials. The relationship between TEPR and antisaccade performance in individuals with psychotic disorders and their relatives has not been investigated. Probands with schizophrenia, schizoaffective disorder, psychotic bipolar disorder, their first-degree relatives, and controls from the B-SNIP study completed antisaccade and VGS tasks. TEPR prior to execution of responses on these tasks was evaluated among controls compared to probands and relatives according to diagnostic groups and neurobiologically defined subgroups (biotypes). Controls demonstrated greater TEPR on antisaccade correct versus error versus VGS trials. TEPR was not differentiated between antisaccade correct versus error trials in bipolar or schizophrenia probands, though was greater on antisaccade compared to prosaccade trials. There was no modulation of TEPR in schizoaffective probands. Relatives of schizophrenia and schizoaffective probands and those with elevated psychosis spectrum traits failed to demonstrate differential TEPR on antisaccade correct versus error trials. No proband or relative biotypes demonstrated differential TEPR on antisaccade correct versus error trials, and only proband biotype 3 and relative biotypes 3 and 2 demonstrated greater TEPR on antisaccade versus VGS trials. Our findings suggest that aberrant modulation of preparatory activity prior to saccade execution contributes to impaired executive cognitive control across the psychosis spectrum, including nonpsychotic relatives with elevated clinical risk. Reduced pupillary modulation under cognitive challenge may thus be a biomarker for the psychosis phenotype.
Collapse
Affiliation(s)
- Tatiana Karpouzian-Rogers
- Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America
| | - John A Sweeney
- Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America
| | - Leah H Rubin
- Departments of Neurology and Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, United States of America; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America
| | - Jennifer McDowell
- Department of Psychology, University of Georgia, Athens, GA, United States of America
| | - Brett A Clementz
- Department of Psychology, University of Georgia, Athens, GA, United States of America
| | - Elliot Gershon
- Psychiatry, University of Chicago, Chicago, IL, United States of America
| | - Matcheri S Keshavan
- Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America
| | - Godfrey D Pearlson
- Departments of Psychiatry and Neurobiology, Yale University and Olin Neuropsychiatric Research Center, Hartford, CT, United States of America
| | - Carol A Tamminga
- Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States of America
| | - James L Reilly
- Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
| |
Collapse
|
3
|
Altered Effective Connectivity within an Oculomotor Control Network in Unaffected Relatives of Individuals with Schizophrenia. Brain Sci 2021; 11:brainsci11091228. [PMID: 34573248 PMCID: PMC8467791 DOI: 10.3390/brainsci11091228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 09/10/2021] [Accepted: 09/12/2021] [Indexed: 11/17/2022] Open
Abstract
The ability to rapidly stop or change a planned action is a critical cognitive process that is impaired in schizophrenia. The current study aimed to examine whether this impairment reflects familial vulnerability to schizophrenia across two experiments comparing unaffected first-degree relatives to healthy controls. First, we examined performance on a saccadic stop-signal task that required rapid inhibition of an eye movement. Then, in a different sample, we investigated behavioral and neural responses (using fMRI) during a stop-signal task variant that required rapid modification of a prepared eye movement. Here, we examined differences between relatives and healthy controls in terms of activation and effective connectivity within an oculomotor control network during task performance. Like individuals with schizophrenia, the unaffected relatives showed behavioral evidence for more inefficient inhibitory processes. Unlike previous findings in individuals with schizophrenia, however, the relatives showed evidence for a compensatory waiting strategy. Behavioral differences were accompanied by more activation among the relatives in task-relevant regions across conditions and group differences in effective connectivity across the task that were modulated differently by the instruction to exert control over a planned saccade. Effective connectivity parameters were related to behavioral measures of inhibition efficiency. The results suggest that individuals at familial risk for schizophrenia were engaging an oculomotor control network differently than controls and in a way that compromises inhibition efficiency.
Collapse
|
4
|
Athanasopoulos F, Saprikis OV, Margeli M, Klein C, Smyrnis N. Towards Clinically Relevant Oculomotor Biomarkers in Early Schizophrenia. Front Behav Neurosci 2021; 15:688683. [PMID: 34177483 PMCID: PMC8222521 DOI: 10.3389/fnbeh.2021.688683] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 05/11/2021] [Indexed: 12/30/2022] Open
Abstract
In recent years, psychiatric research has focused on the evaluation and implementation of biomarkers in the clinical praxis. Oculomotor function deviances are among the most consistent and replicable cognitive deficits in schizophrenia and have been suggested as viable candidates for biomarkers. In this narrative review, we focus on oculomotor function in first-episode psychosis, recent onset schizophrenia as well as individuals at high risk for developing psychosis. We critically discuss the evidence for the possible utilization of oculomotor function measures as diagnostic, susceptibility, predictive, monitoring, and prognostic biomarkers for these conditions. Based on the current state of research we conclude that there are not sufficient data to unequivocally support the use of oculomotor function measures as biomarkers in schizophrenia.
Collapse
Affiliation(s)
- Fotios Athanasopoulos
- 2nd Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.,Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece
| | - Orionas-Vasilis Saprikis
- 2nd Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.,Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece
| | - Myrto Margeli
- 2nd Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.,Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece
| | - Christoph Klein
- 2nd Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.,Department of Child and Adolescent Psychiatry, Medical Faculty, University of Freiburg, Freiburg, Germany.,Department of Child and Adolescent Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany
| | - Nikolaos Smyrnis
- 2nd Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.,Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece
| |
Collapse
|
5
|
Eye movement abnormalities in essential tremor versus tremor dominant Parkinson’s disease. Clin Neurophysiol 2019; 130:683-691. [DOI: 10.1016/j.clinph.2019.01.026] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 01/14/2019] [Accepted: 01/31/2019] [Indexed: 11/21/2022]
|
6
|
Cutsuridis V. Behavioural and computational varieties of response inhibition in eye movements. Philos Trans R Soc Lond B Biol Sci 2017; 372:rstb.2016.0196. [PMID: 28242730 DOI: 10.1098/rstb.2016.0196] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/05/2016] [Indexed: 11/12/2022] Open
Abstract
Response inhibition is the ability to override a planned or an already initiated response. It is the hallmark of executive control as its deficits favour impulsive behaviours, which may be detrimental to an individual's life. This article reviews behavioural and computational guises of response inhibition. It focuses only on inhibition of oculomotor responses. It first reviews behavioural paradigms of response inhibition in eye movement research, namely the countermanding and antisaccade paradigms, both proven to be useful tools for the study of response inhibition in cognitive neuroscience and psychopathology. Then, it briefly reviews the neural mechanisms of response inhibition in these two behavioural paradigms. Computational models that embody a hypothesis and/or a theory of mechanisms underlying performance in both behavioural paradigms as well as provide a critical analysis of strengths and weaknesses of these models are discussed. All models assume the race of decision processes. The decision process in each paradigm that wins the race depends on different mechanisms. It has been shown that response latency is a stochastic process and has been proven to be an important measure of the cognitive control processes involved in response stopping in healthy and patient groups. Then, the inhibitory deficits in different brain diseases are reviewed, including schizophrenia and obsessive-compulsive disorder. Finally, new directions are suggested to improve the performance of models of response inhibition by drawing inspiration from successes of models in other domains.This article is part of the themed issue 'Movement suppression: brain mechanisms for stopping and stillness'.
Collapse
|
7
|
Ettinger U, Aichert DS, Wöstmann N, Dehning S, Riedel M, Kumari V. Response inhibition and interference control: Effects of schizophrenia, genetic risk, and schizotypy. J Neuropsychol 2017; 12:484-510. [DOI: 10.1111/jnp.12126] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 03/06/2017] [Indexed: 01/18/2023]
Affiliation(s)
| | | | | | - Sandra Dehning
- Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy; University of Munich; Germany
| | | | - Veena Kumari
- Research and Development; Sovereign Health Group; San Clemente California USA
| |
Collapse
|
8
|
Caldani S, Bucci MP, Lamy JC, Seassau M, Bendjemaa N, Gadel R, Gaillard R, Krebs MO, Amado I. Saccadic eye movements as markers of schizophrenia spectrum: Exploration in at-risk mental states. Schizophr Res 2017; 181:30-37. [PMID: 27639418 DOI: 10.1016/j.schres.2016.09.003] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Revised: 09/01/2016] [Accepted: 09/01/2016] [Indexed: 01/27/2023]
Abstract
Schizophrenia is a neurodevelopmental disease with cognitive and motor impairments. Motor dysfunctions, such as eye movements or Neurological Soft Signs (NSS), are proposed as endophenotypic markers. Antisaccade (AS) and memory-guided saccades (MGS), two markers of inhibitory control mechanism, are altered in both patients with schizophrenia and their relatives, although these tools may have different sensitivities. Recently, emphasis has been put on identifying markers predictive of psychosis transition in subjects with ultra-high-risk psychosis in order to develop targeted prevention. This study investigates AS and MGS in 46 patients with schizophrenia, 23 ultra-high-risk subjects, and 39 full siblings compared to 47 healthy volunteers. NSS were assessed as a marker of abnormal neurodevelopment. The results revealed more errors in MGS in patients, ultra-high-risk subjects and siblings, than in controls, and more specifically ultra-high-risk subjects with high NSS scores. By contrast, the error rate in AS was significantly higher only in patients with schizophrenia compared to controls. These findings suggest that MGS could be more accurate to detect deficient inhibitory processes as a marker of vulnerability before the onset of schizophrenia. The use of the different paradigms (AS, MGS) revealed distinct profiles depending on the stage of the disease, indicating that some alterations could be pure endophenotypic markers of vulnerability for schizophrenia, while others could be markers of the disease progression.
Collapse
Affiliation(s)
- Simona Caldani
- UMR 1141 Inserm-Université Paris Diderot, Hôpital Robert Debré, 75019 Paris, France; INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France
| | - Maria Pia Bucci
- UMR 1141 Inserm-Université Paris Diderot, Hôpital Robert Debré, 75019 Paris, France
| | - Jean-Charles Lamy
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France
| | | | - Narjes Bendjemaa
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France
| | - Rémi Gadel
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France
| | - Raphael Gaillard
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France
| | - Marie-Odile Krebs
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France.
| | - Isabelle Amado
- INSERM U894, Laboratory of Pathophysiology of Psychiatric Diseases, Center of Psychiatry and Neurosciences, Institut de Psychiatrie, GDR3557, France; University Paris Descartes, Faculty of Medicine Paris Descartes, Service Hospitalo-Universitaire, Sainte-Anne Hospital, Paris, France
| |
Collapse
|
9
|
Myles JB, Rossell SL, Phillipou A, Thomas E, Gurvich C. Insights to the schizophrenia continuum: A systematic review of saccadic eye movements in schizotypy and biological relatives of schizophrenia patients. Neurosci Biobehav Rev 2016; 72:278-300. [PMID: 27916709 DOI: 10.1016/j.neubiorev.2016.10.034] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2015] [Revised: 10/05/2016] [Accepted: 10/27/2016] [Indexed: 10/20/2022]
Abstract
Myles, J.B., S. Rossell, A. Phillipou, Thomas, E and C. Gurvich. A systematic review of saccadic eye movements across the schizophrenia continuum: Characterisation, pathophysiology and genetic associations. NEUROSCI BIOBEHAV REV 21(1) XXX-XXX, 2015. One of the cognitive hallmarks of schizophrenia is impaired eye movements, particularly for the antisaccade task. Less saccade research has been conducted in relation to the broader schizophrenia continuum, that is, people with high schizotypy or first-degree relatives of people with schizophrenia. This systematic review sought to identify, collate and appraise prosaccade, antisaccade and memory-guided saccade studies involving behavioural, neuroimaging and genetic data published between 1980 and September 2016 in individuals with high schizotypy and first-degree relatives. A systematic literature search was conducted, using Ovid MEDLINE, PsycINFO, PubMed and SCOPUS databases. Of 913 references screened, 18 schizotypy, 29 family studies and two schizotypy and relatives articles studies were eligible for inclusion. Antisaccade error rate was the most consistent deficit found for high schizotypy. Relatives had intermediate antisaccade error rates between patients and healthy controls. Results from the limited genetic and neuroimaging studies echoed schizophrenia findings. Confounds were also identified. It was concluded that future research is required to refine the saccade endophenotype and to expand genetic and neuroimaging research.
Collapse
Affiliation(s)
- Jessica B Myles
- Monash Alfred Psychiatry research centre, The Alfred Hospital and Monash University Central Clinical School, Melbourne, Australia
| | - Susan L Rossell
- Monash Alfred Psychiatry research centre, The Alfred Hospital and Monash University Central Clinical School, Melbourne, Australia; Brain and Psychological Sciences Research Centre, Swinburne University of Technology, Melbourne, Australia; Department of Psychiatry, St Vincent's Hospital, Melbourne, Australia
| | - Andrea Phillipou
- Department of Psychiatry, St Vincent's Hospital, Melbourne, Australia; Department of Psychiatry, The University of Melbourne, Melbourne, Australia; Department of Mental Health, The Austin Hospital, Melbourne, Australia
| | - Elizabeth Thomas
- Monash Alfred Psychiatry research centre, The Alfred Hospital and Monash University Central Clinical School, Melbourne, Australia
| | - Caroline Gurvich
- Monash Alfred Psychiatry research centre, The Alfred Hospital and Monash University Central Clinical School, Melbourne, Australia.
| |
Collapse
|
10
|
Reilly JL, Frankovich K, Hill S, Gershon ES, Keefe RSE, Keshavan MS, Pearlson GD, Tamminga CA, Sweeney JA. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr Bull 2014; 40:1011-21. [PMID: 24080895 PMCID: PMC4133662 DOI: 10.1093/schbul/sbt132] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
BACKGROUND Elevated antisaccade error rate, reflecting problems with inhibitory behavioral control, is a promising intermediate phenotype for schizophrenia. Here, we consider whether it marks liability across psychotic disorders via common or different neurophysiological mechanisms and whether it represents a neurocognitive risk indicator apart from the generalized cognitive deficit. METHODS Schizophrenia (n = 267), schizoaffective (n = 150), and psychotic bipolar (n = 202) probands, their first-degree relatives (ns = 304, 193, 242, respectively), and healthy controls (n = 244), participating in the Bipolar-Schizophrenia Network on Intermediate Phenotypes consortium, performed antisaccade and prosaccade tasks and completed a neuropsychological battery. RESULTS Antisaccade error rate was elevated in proband groups with greatest deficit observed in schizophrenia and was unrelated to symptoms and antipsychotic treatment. Increased error rate was also observed among relatives, even those without history of psychosis or psychosis spectrum personality traits. Relatives' deficits were similar across proband diagnoses. Error rate was familial and remained elevated in proband and relative groups after accounting for generalized cognitive impairment. Speed of attentional shifting, indexed by prosaccade latency, was similarly influenced in all groups by manipulations that freed vs increasingly engaged attention systems and was inversely associated with antisaccade error rate in all but schizophrenia probands. CONCLUSIONS These findings indicate that elevated antisaccade error rate represents an intermediate phenotype for psychosis across diagnostic categories, and that it tracks risk beyond that attributable to the generalized cognitive deficit. The greater severity of antisaccade impairment in schizophrenia and its independence from attention shifting processes suggest more severe and specific prefrontal inhibitory control deficits in this disorder.
Collapse
Affiliation(s)
- James L. Reilly
- Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL;,*To whom correspondence should be addressed; Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 446 East Ontario Street, Suite. 7-100, Chicago, IL 60611, US; tel: 312-503-4809, fax: 312-503-0527, e-mail:
| | - Kyle Frankovich
- Center for Mind and Brain and Department of Psychology, University of California at Davis, Davis, CA
| | - Scot Hill
- Department of Psychology, Rosalind Franklin University of Medicine and Science, Chicago, IL
| | - Elliot S. Gershon
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL
| | | | - Matcheri S. Keshavan
- Beth Israel Deaconess Hospital and Massachusetts Mental Health Center, Harvard Medical School, Boston, MA
| | - Godfrey D. Pearlson
- Olin Neuropsychiatry Research Center, Yale School of Medicine, New Haven, CT;,Department of Psychiatry, Institute of Living/Hartford Hospital, Hartford, CT
| | - Carol A. Tamminga
- Department of Psychiatry, UT Southwestern Medical School, Dallas, TX
| | - John A. Sweeney
- Department of Psychiatry, UT Southwestern Medical School, Dallas, TX
| |
Collapse
|
11
|
Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia. Brain Cogn 2011; 77:223-30. [DOI: 10.1016/j.bandc.2011.08.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2010] [Revised: 07/26/2011] [Accepted: 08/04/2011] [Indexed: 02/06/2023]
|
12
|
Schmechtig A, Vassos E, Kumari V, Hutton SB, Collier DA, Morris RG, Williams SCR, Ettinger U. Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements. GENES BRAIN AND BEHAVIOR 2010; 9:621-7. [PMID: 20497232 DOI: 10.1111/j.1601-183x.2010.00594.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Neuregulin 1 (NRG1) has been identified as one of the leading candidate genes for schizophrenia. However, its functional mechanisms and its effects on neurocognition remain unclear. In this study, we used two well-established oculomotor endophenotypes, the antisaccade (AS) and smooth pursuit eye movement (SPEM) tasks, to investigate the functional mechanisms of a single nucleotide polymorphism (SNP) in NRG1 (rs3924999) at the neurocognitive level in a healthy volunteer sample. A total of 114 healthy Caucasian volunteers completed genotyping for NRG1 rs3924999 and infrared oculographic assessment of AS and SPEM (at target velocities of 12 degrees , 24 degrees and 36 degrees per second). Additionally, self-report questionnaires of schizotypy, neuroticism, attention deficit hyperactivity and obsessive-compulsive traits were included. A significant effect of rs3924999 genotype, with gender as a covariate, was found for AS amplitude gain (P < 0.01), with an increasing number of A alleles being associated with increasingly hypermetric performance. No statistically significant associations were found for other AS and SPEM variables or questionnaire scores. These findings indicate that NRG1 rs3924999 affects spatial accuracy on the AS task, suggesting an influence of the gene on the neural mechanisms underlying visuospatial sensorimotor transformations, a mechanism that has been previously found to be impaired in patients with schizophrenia and their relatives.
Collapse
Affiliation(s)
- A Schmechtig
- Department of Neuroimaging, King's College Institute of Psychiatry, London, UK.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Harris MS, Reilly JL, Thase ME, Keshavan MS, Sweeney JA. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Res 2009; 170:150-6. [PMID: 19906441 PMCID: PMC2792232 DOI: 10.1016/j.psychres.2008.10.031] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/12/2008] [Revised: 09/03/2008] [Accepted: 10/23/2008] [Indexed: 11/25/2022]
Abstract
Recent evidence indicates common genetic, neurobiological, and psychopharmacological aspects of schizophrenia and psychotic affective disorders. Some similarities in neurocognitive deficits associated with these disorders have also been reported. We investigated performance on antisaccade and visually-guided saccade tasks in treatment-naïve first-episode psychosis patients (schizophrenia n=59, major depression n=15, bipolar disorder n=9), matched non-psychotic major depression patients (n=40), and matched healthy individuals (n=106). All psychosis groups displayed elevated antisaccade error rates relative to healthy individuals. Antisaccade latencies were elevated in schizophrenia, but no significant error rate or latency differences were observed among psychosis groups. For schizophrenia only, shorter visually guided saccade latencies were associated with higher antisaccade error rates. Schizophrenia was also the only group without a significant relationship between visually guided and antisaccade latencies. Reflexive saccades were unimpaired except in psychotic unipolar depression, where saccades were hypometric. As in schizophrenia, antisaccade abnormalities are present in affective psychoses, even early in the course of illness and prior to treatment. Disturbances in frontostriatal systems are believed to occur in both affective psychoses and schizophrenia, potentially causing some similar cognitive abnormalities across psychotic disorders. However, the distinct pattern of dysfunction in schizophrenia across oculomotor paradigms suggests possible unique causes of their observed oculomotor performance deficits.
Collapse
Affiliation(s)
- Margret S.H. Harris
- Center for Cognitive Medicine, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
| | - James L. Reilly
- Center for Cognitive Medicine, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
| | - Michael E. Thase
- Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA,Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - Matcheri S. Keshavan
- Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, USA,Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - John A. Sweeney
- Center for Cognitive Medicine, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA,Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA,Center for Cognitive Medicine, 912 South Wood Street, MC 913, University of Illinois at Chicago, Chicago, IL 60612, USA, Phone: 312-413-9205, Fax: 312-413-8837,
| |
Collapse
|
14
|
Gooding DC, Basso MA. The tell-tale tasks: a review of saccadic research in psychiatric patient populations. Brain Cogn 2008; 68:371-90. [PMID: 18950927 DOI: 10.1016/j.bandc.2008.08.024] [Citation(s) in RCA: 113] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/26/2008] [Indexed: 10/21/2022]
Abstract
This review focuses on saccade research with adult psychiatric patients. It begins with an introduction of the various types of saccades and the tasks used to evoke them. The functional significance of the different types of eye movements is briefly discussed. Research findings regarding the saccadic performance of different adult psychiatric patient populations are discussed in detail, with particular emphasis on findings regarding error rates, response latencies, and any specific task parameters that might affect those variables. Findings regarding the symptom, neurocognitive, and neural correlates of saccadic performance and the functional significance of patients' saccadic deficits are also discussed. We also discuss the saccadic deficits displayed by various patient groups in terms of circuitry (e.g. cortical/basal ganglia circuits) that may be implicated in the underlying pathophysiology of several of these disorders. Future directions for research in this growing area are offered.
Collapse
Affiliation(s)
- Diane C Gooding
- Department of Psychology, University of Wisconsin-Madison, College of Letters and Sciences, 1202 West Johnson Street, Madison, WI 53706, USA.
| | | |
Collapse
|
15
|
Calkins ME, Iacono WG, Ones DS. Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain Cogn 2008; 68:436-61. [PMID: 18930572 DOI: 10.1016/j.bandc.2008.09.001] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/08/2008] [Indexed: 10/21/2022]
Abstract
Several forms of eye movement dysfunction (EMD) are regarded as promising candidate endophenotypes of schizophrenia. Discrepancies in individual study results have led to inconsistent conclusions regarding particular aspects of EMD in relatives of schizophrenia patients. To quantitatively evaluate and compare the candidacy of smooth pursuit, saccade and fixation deficits in first-degree biological relatives, we conducted a set of meta-analytic investigations. Among 18 measures of EMD, memory-guided saccade accuracy and error rate, global smooth pursuit dysfunction, intrusive saccades during fixation, antisaccade error rate and smooth pursuit closed-loop gain emerged as best differentiating relatives from controls (standardized mean differences ranged from .46 to .66), with no significant differences among these measures. Anticipatory saccades, but no other smooth pursuit component measures were also increased in relatives. Visually-guided reflexive saccades were largely normal. Moderator analyses examining design characteristics revealed few variables affecting the magnitude of the meta-analytically observed effects. Moderate effect sizes of relatives v. controls in selective aspects of EMD supports their endophenotype potential. Future work should focus on facilitating endophenotype utility through attention to heterogeneity of EMD performance, relationships among forms of EMD, and application in molecular genetics studies.
Collapse
Affiliation(s)
- Monica E Calkins
- Department of Psychiatry, University of Pennsylvania School of Medicine, Neuropsychiatry Section, Schizophrenia Research Center and Brain Behavior Laboratory, Philadelphia, PA 19104, USA.
| | | | | |
Collapse
|
16
|
Does performance on the standard antisaccade task meet the co-familiality criterion for an endophenotype? Brain Cogn 2008; 68:462-75. [PMID: 18842329 DOI: 10.1016/j.bandc.2008.08.027] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/26/2008] [Indexed: 12/22/2022]
Abstract
The "co-familiality" criterion for an endophenotype has two requirements: (1) clinically unaffected relatives as a group should show both a shift in mean performance and an increase in variance compared with controls; (2) performance scores should be heritable. Performance on the antisaccade task is one of several candidate endophenotypes for schizophrenia. In this paper we examine whether the various measures of performance on the standard version of the antisaccade task meet the co-familiality criterion for an endophenotype. The three measures of performance-reflexive saccade errors, latency of correct antisaccades, and gain-show a wide range of effect sizes and variance ratios as well as evidence of significant or near significant heterogeneity. The estimated mean effect sizes [Cohen's d: error rate: 0.34 (SD: 0.29); latency: 0.33 (SD: 0.30); gain: 0.54 (SD: 0.38)] are significantly greater than 0, but the magnitude of the departures from 0 is relatively small, corresponding to modest effect sizes. The width of the 95% confidence intervals for the estimated effect sizes (error rate: 0.2-0.49; latency: 0.17-0.50; gain: 0.23-0.85) and the coefficients of variation in effect sizes (error rate: 85.3%; latency: 90.9%; gain: 68.4%) reflect heterogeneity in effect sizes. The effect sizes for error rate showed statistically significant heterogeneity and those for latency (P=.07) and gain (P=.09) showed a trend toward heterogeneity. These results indicate that the effect sizes are not consistent with a single mean and that the average effect size may be a biased estimate of the magnitude of differences in performance between relatives of schizophrenics and controls. Relatives of schizophrenics show a small but significant increase in variance in error rate, but the confidence interval is broad, perhaps reflecting the heterogeneity in effect size. The variance ratios for latency and gain did not differ in relatives of schizophrenics and controls. Performance, as measured by error rate, is moderately heritable. The data do not provide compelling support for a consistent shift in mean or variance in relatives of schizophrenia patients compared with nonpsychiatric controls, both of which are required for a major gene involved in co-familial transmission. This set of findings suggests that although intra-familial resemblance in antisaccade performance is due in part to genetic factors, it may not be related to a schizophrenia genotype. Based on the current literature, it would be premature to conclude that any of the measures of antisaccade performance unambiguously meets the co-familiality criterion for an endophenotype.
Collapse
|